{
    "Trade/Device Name(s)": [
        "NOVEOS Immunoanalyzer System",
        "NOVEOS Specific IgE (sIgE) Assay",
        "Capture Reagent D002",
        "Dermatophagoides farinae"
    ],
    "Submitter Information": "Hycor Biomedical",
    "510(k) Number": "K191510",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051218"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHB"
    ],
    "Summary Letter Date": "June 4, 2019",
    "Summary Letter Received Date": "June 6, 2019",
    "Submission Date": "July 31, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.5750"
    ],
    "Regulation Name(s)": [
        "Radioallergosorbent (RAST) Immunological Test System"
    ],
    "Analyte Class(es)": [
        "allergy",
        "immunology"
    ],
    "Analyte(s)": [
        "Allergen-specific IgE",
        "Dermatophagoides farinae IgE"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "NOVEOS Immunoassay Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Immunometric assay",
        "Chemiluminescent",
        "Fluorescence-adjusted",
        "Magnetic microparticle-based"
    ],
    "Methodologies": [
        "Immunometric assay",
        "Chemiluminescent immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Analyzer",
        "Capture Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for NOVEOS Specific IgE assay system for quantifying allergen-specific IgE to Dermatophagoides farinae using immunometric chemiluminescent technology",
    "Indications for Use Summary": "In vitro quantitative assay for the measurement of allergen specific IgE in human serum to aid in the clinical diagnosis of IgE mediated allergic disorders, used with the NOVEOS Immunoassay Analyzer in clinical laboratories",
    "fda_folder": "Immunology"
}